EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)

Combination of Radiation Therapy and Irreversible Electroporation for Intermediate-Risk Prostate Cancer (RTIRE): A Phase 1 Trial

Timothy D McClure iD, Shu Wang iD, Karla V Ballman iD, Marshall Diven, Joseph R Osborne iD, Elisabeth O'Dwyer, Jennifer Piscopo, Francesca Khani, Ariel Marciscano, Bashir Al Hussein Al Awamlh iD, Christopher Barbieri iD, Himanshu Nagar iD

Radiology · 01.07.2026 · 320 (1)

DOI: 10.1148/radiol.250848 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift Radiology, erschienen am 01.07.2026. Verfasst von Timothy D McClure und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, NewYork-Presbyterian Hospital, Weill Cornell Medicine, 525 E 68th St, Starr 900, New York, NY 10065. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Irreversible Electroporation Therapy. Die Arbeit nennt 21 Literaturangaben. Gefördert von: Clinical and Translational Science Center, Weill Cornell Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Treatment of participants with intermediate-risk prostate cancer with focal irreversible electroporation and radiation therapy was technically feasible and showed acceptable patient-reported outcomes and no severe adverse events over 1 year.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsIrreversible Electroporation TherapyHumansMaleProspective StudiesAgedMiddle AgedCombined Modality TherapyFeasibility StudiesMagnetic Resonance ImagingTreatment OutcomeQuality of Life

Autor:innen und Institutionen

  • Department of Urology, NewYork-Presbyterian Hospital, Weill Cornell Medicine, 525 E 68th St, Starr 900, New York, NY 10065.
  • Department of Radiology, NewYork-Presbyterian Hospital, Weill Cornell Medicine, New York, NY.
  • Department of Quantitative Health Science, Mayo Clinic, Rochester, Minn.
  • Department of Radiation Oncology, NewYork-Presbyterian Brooklyn Methodist Hospital, New York, NY.
  • Department of Pathology and Laboratory Medicine, NewYork-Presbyterian Hospital, Weill Cornell Medicine, New York, NY.
  • Department of Radiation Oncology, Massachusetts General Hospital, Boston, Mass.

ORCID-Profile: Timothy D McClure, Shu Wang, Karla V Ballman, Joseph R Osborne, Bashir Al Hussein Al Awamlh, Christopher Barbieri, Himanshu Nagar

Förderung

  • Clinical and Translational Science Center, Weill Cornell Medicine

Zitieren

APA

McClure, T. D., Wang, S., Ballman, K. V., Diven, M., Osborne, J. R., O'Dwyer, E., Piscopo, J., Khani, F., Marciscano, A., Al Hussein Al Awamlh, B., Barbieri, C., & Nagar, H. (2026). Combination of Radiation Therapy and Irreversible Electroporation for Intermediate-Risk Prostate Cancer (RTIRE): A Phase 1 Trial. Radiology, 320(1). https://doi.org/10.1148/radiol.250848

Vancouver

McClure TD, Wang S, Ballman KV, Diven M, Osborne JR, O'Dwyer E, et al. Combination of Radiation Therapy and Irreversible Electroporation for Intermediate-Risk Prostate Cancer (RTIRE): A Phase 1 Trial. Radiology. 2026;320(1). doi:10.1148/radiol.250848

BibTeX
@article{McClure2026,
  author = {McClure, Timothy D and Wang, Shu and Ballman, Karla V and Diven, Marshall and Osborne, Joseph R and O'Dwyer, Elisabeth and Piscopo, Jennifer and Khani, Francesca and Marciscano, Ariel and Al Hussein Al Awamlh, Bashir and Barbieri, Christopher and Nagar, Himanshu},
  title = {Combination of Radiation Therapy and Irreversible Electroporation for Intermediate-Risk Prostate Cancer (RTIRE): A Phase 1 Trial},
  journal = {Radiology},
  year = {2026},
  volume = {320},
  number = {1},
  doi = {10.1148/radiol.250848}
}
Kostenlos starten →